ClinicalTrials.Veeva

Menu

Treatment of Early Childhood Caries Using Silver Diammine Fluoride and Sodium Fluoride Tricalciumphosphate and the Effects on Oral Health Related Quality of Life

U

Universiti Sains Malaysia

Status and phase

Invitation-only
Phase 4

Conditions

Behavior, Child
Dental Caries
Dental Caries Extending Into Dentin
Dental Caries in Children
Early Childhood Caries
Quality of Life

Treatments

Drug: Topical application of 38% Silver Diammine Fluoride Solution
Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05772039
USM/JEPeM/20010069

Details and patient eligibility

About

There is still a need for the assessment of different minimal intervention strategies and treatments focusing on the prevention and arrest of carious lesions of primary molars The evidence-based clinical practice guideline on non-restorative treatments for cavitated carious lesions advocate the use of silver diammine fluoride biannually for high caries risk patients

Full description

Although SDF has been proven to be highly effective in carious lesion arrest and prevention, the staining effect, metallic taste due to silver content and the minimal mucosal irritation have been noted as primary cause of disinterest among clinicians in the use of this material.

The use of NaF-fTCP as a caries preventive material has not been studied widely. The importance of oral hygiene education and diet modification to achieve an effective caries control has been widely discussed. The off-label use of NaF-fTCP as a caries arresting agent has not been studied on primary dentition. There is a dearth of evidence regarding the effectiveness of NaF-fTCP towards caries arrest and prevention in pragmatic settings.

A comparison between the SDF and NaF-fTCP application on the cavitated carious primary molars and their effect on the oral health-related quality of life of the children has not been published in the literature.

Enrollment

72 estimated patients

Sex

All

Ages

4 to 6 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Children will be invited to participate in the trial if they fulfil the entire selection criteria as described below:

  • 4 to 6 years-of-age
  • Identification of one or more carious primary molars without involvement of the pulp confirmed by bitewing radiographs
  • Up to three teeth per each participant will be selected for intervention
  • Has normal salivary flow rate
  • Does not consume medications regularly for any medical condition
  • Has not or will not receive any fluoride therapy or relevant dental therapy from other dental sources within the last six months

Exclusion criteria

Children will be excluded from the trial if they fulfil any of the following criteria:

  • Presence of any pain, ulceration, fistula/sinus or an abscess
  • Premature hypermobility of carious teeth which can be potentially included in the study
  • History of allergy to any product containing silver compounds
  • Siblings of the participants will not be allowed to participate to ensure any chance of ECOHIS duplication.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

72 participants in 6 patient groups

Topical application of 38% Silver Diammine Fluoride Solution at Baseline
Active Comparator group
Description:
* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.
Treatment:
Drug: Topical application of 38% Silver Diammine Fluoride Solution
Topical application of 38% Silver Diammine Fluoride Solution at 6 months
Active Comparator group
Description:
* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.
Treatment:
Drug: Topical application of 38% Silver Diammine Fluoride Solution
Topical application of 38% Silver Diammine Fluoride Solution at 12 months
Active Comparator group
Description:
* SDF is known for its corrosive nature therefore a plastic container or dappen dish will be used. * 1 drop (0.05 ml) will be dispensed on a plastic container. * 1 drop (2.24 F-ion mg/dose) SDF treats up to 5 tooth surfaces. * Ultrafine microbrushes will be used to apply varnish.
Treatment:
Drug: Topical application of 38% Silver Diammine Fluoride Solution
Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at baseline
Experimental group
Description:
* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.
Treatment:
Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 6 months
Experimental group
Description:
* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.
Treatment:
Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish
Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish at 12 months
Experimental group
Description:
* 0.25 ml of the solution will be used which contains 12.5 mg of fluoride. * Thin layer will be applied with sweeping horizontal brush strokes to all teeth present.
Treatment:
Drug: Topical application of 5% Sodium Fluoride with functional Tricalcium phosphate Varnish

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems